Evaluation of Effectiveness and Safety of PROMUS Element Stent (IRIS-ELEMENT )
NCT01350791 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3001
Last updated 2017-07-21
Summary
This study is a non-randomized, prospective, open-label registry to compare the efficacy and safety of Promus Element stents versus first-generation drug-eluting stent (DES) in patients with coronary artery disease.
Conditions
Sponsors & Collaborators
-
CardioVascular Research Foundation, Korea
collaborator OTHER -
Boston Scientific Corporation
collaborator INDUSTRY -
Seung-Jung Park
lead OTHER
Principal Investigators
-
Seung-Jung Park, MD, PhD · Asan Medical Center
-
Ki Bae Seung, MD, PhD · Seoul St. Mary's Hospital, Catholic University of Korea
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-05-31
- Primary Completion
- 2013-10-31
- Completion
- 2016-12-31
Countries
- South Korea
Study Locations
More Related Trials
-
Prospective, Randomized, Multicenter Trial to Assess PROMUS™ Element™ Stent
NCT01285999 ·Status: COMPLETED ·Phase: NA
-
Comparison of Biolimus-eluting Biodegradable Polymer, Everolimus-eluting and Sirolimus-eluting Coronary Stents
NCT01268371 ·Status: UNKNOWN ·Phase: PHASE4
-
IRIS-Synergy Cohort in the IRIS-DES Registry
NCT02720419 ·Status: ACTIVE_NOT_RECRUITING
-
Trial to Assess the Everolimus-Eluting Coronary Stent System (PROMUS Element) for Coronary Revascularization
NCT01342822 ·Status: UNKNOWN
-
Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis - SAfety & EffectiveneSS of Drug-ElUting Stents & Anti-platelet REgimen
NCT01267734 ·Status: UNKNOWN ·Phase: PHASE4
-
GENOSS Coronary Stent Clinical Trial
NCT05444452 ·Status: RECRUITING ·Phase: NA
-
Efficacy and Safety of GENOSS® SES in Patients With Acute Coronary Syndrome (GENOSS ACS)
NCT06075368 ·Status: ACTIVE_NOT_RECRUITING
-
PROMUS™ Element™ Everolimus-Eluting Coronary Stent System European Post-Approval Surveillance Study
NCT01148329 ·Status: COMPLETED
-
Evaluation of Effectiveness and Safety of NOBORI Stent
NCT01348360 ·Status: COMPLETED
-
Korean Nationwide Multicenter Pooled Registry of Drug-Eluting Stents
NCT03507205 ·Status: COMPLETED
-
Study Examining the PROMUS Element Everolimus-eluting Stent in Multi-center Coronary Intervention of Complex Arterial Lesion Subsets
NCT01670318 ·Status: UNKNOWN ·Phase: NA
-
Harmonizing Optimal Strategy for Treatment of Coronary Artery Diseases Trial - Comparison of REDUCTION of PrasugrEl Dose & POLYmer TECHnology in ACS Patients (HOST REDUCE POLYTECH RCT Trial)
NCT02193971 ·Status: COMPLETED ·Phase: PHASE4
-
A Prospective, Multi-center Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element™)
NCT00824434 ·Status: COMPLETED ·Phase: PHASE3
-
Effectiveness and Safety of Abluminal Biodegradable Polymer Sirolimus-eluting Stent (GENOSS® DES)
NCT06086496 ·Status: ENROLLING_BY_INVITATION
-
NG PROMUS Stent System for the Treatment of Atherosclerotic Coronary Lesions
NCT01703000 ·Status: COMPLETED ·Phase: NA
-
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions in Small Vessels
NCT01498692 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Everolimus-Eluting Versus Zotarolimus-Eluting Sten for Coronary Lesions in Acute Myocardial Infarction
NCT01347554 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of the Biolimus A9-eluting Stent With the Zotarolimus -Eluting Stent in Multi-vessel PCI
NCT01947439 ·Status: COMPLETED ·Phase: NA
-
PROMUS Element Japan Small Vessel Trial
NCT01080261 ·Status: COMPLETED ·Phase: PHASE3
-
New Generation Drug Eluting Stent for In-stent Restenosis of Drug Eluting Stent( RESTENT-ISR Trial )
NCT01365572 ·Status: UNKNOWN ·Phase: PHASE4
-
Genoss DES in Patients With a High Risk of Ischemic Events (GENTLE Registry)
NCT05448625 ·Status: COMPLETED
-
International Randomized Comparison Between DES Limus Carbostent and Taxus DES in the Treatment of De-novo Coronary Lesions
NCT01373502 ·Status: COMPLETED ·Phase: NA
-
A Prospective Evaluation in a Randomized Trial of TAXUS in the Treatment of De Novo Coronary Artey Lesions
NCT00693979 ·Status: UNKNOWN ·Phase: PHASE1
-
Registry to Evaluate the Efficacy of Zotarolimus-Eluting Stent
NCT00960908 ·Status: UNKNOWN
-
Evaluation of the First, Second, and New Drug-Eluting Stents in Routine Clinical Practice
NCT01186133 ·Status: RECRUITING